Literature DB >> 29146290

Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.

An-Li Wang1, Steven B Lowen2, Igor Elman3, Zhenhao Shi4, Victoria P Fairchild4, Alexander Bouril4, Ruben C Gur5, Daniel D Langleben5.   

Abstract

BACKGROUND: Chronic opioid misuse is associated with reduced sensitivity to natural rewards and social motivation deficits that include impaired caregiving. The neurobiological mechanisms underlying these deficits and their response to treatment are not well understood. Baby schema (Kindchenschema) is a set of juvenile physical features, which is perceived as "cute" and triggers motivation for caregiving. Recent studies suggest that the "baby schema effect" is mediated by the brain "reward" network. We studied the impact of opioid antagonist treatment on the baby schema response in patients with opioid use disorder.
METHODS: Forty-seven (24 F) recently detoxified patients with opioid use disorder underwent functional magnetic resonance imaging (fMRI) while viewing infant portraits that were parametrically manipulated for baby schema content and rating them for cuteness, at baseline and during treatment with the injectable extended release opioid antagonist naltrexone (XRNTX). The study was not placebo-controlled.
RESULTS: The behavioral effect of baby schema, indexed by "cuteness" ratings, was present and unaffected by XRNTX. The brain response to baby schema was absent at baseline, but present in the bilateral ventral striatum after two weeks of XRNTX treatment. The decline in self-reported craving for opioids was positively correlated with the brain fMRI response to baby schema in the bilateral ventral striatum.
CONCLUSIONS: Opioid antagonist treatment modulated the brain reward system response to a marker of caregiving motivation in patients with opioid use disorder. Neural response to baby schema may offer a novel probe of social motivation and affiliative behaviors in this population.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baby schema; Caregiving; Cuteness; Functional magnetic resonance imaging; Naltrexone; Opioid; Social motivation

Mesh:

Substances:

Year:  2017        PMID: 29146290      PMCID: PMC6043353          DOI: 10.1016/j.jsat.2017.10.007

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  73 in total

Review 1.  A neurobehavioral model of affiliative bonding: implications for conceptualizing a human trait of affiliation.

Authors:  Richard A Depue; Jeannine V Morrone-Strupinsky
Journal:  Behav Brain Sci       Date:  2005-06       Impact factor: 12.579

2.  Characterizing stimulus-response functions using nonlinear regressors in parametric fMRI experiments.

Authors:  C Büchel; A P Holmes; G Rees; K J Friston
Journal:  Neuroimage       Date:  1998-08       Impact factor: 6.556

3.  Baby Schema in Infant Faces Induces Cuteness Perception and Motivation for Caretaking in Adults.

Authors:  Melanie L Glocker; Daniel D Langleben; Kosha Ruparel; James W Loughead; Ruben C Gur; Norbert Sachser
Journal:  Ethology       Date:  2009-03       Impact factor: 1.897

4.  Naltrexone alters the processing of social and emotional stimuli in healthy adults.

Authors:  Margaret C Wardle; Anya K Bershad; Harriet de Wit
Journal:  Soc Neurosci       Date:  2016-01-22       Impact factor: 2.083

5.  Mu 1 opioid receptor involvement in maternal behavior.

Authors:  P E Mann; G W Pasternak; R S Bridges
Journal:  Physiol Behav       Date:  1990-01

6.  The effects of morphine, naloxone, and κ opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus).

Authors:  B J Ragen; N Maninger; S P Mendoza; K L Bales
Journal:  Neuroscience       Date:  2014-12-06       Impact factor: 3.590

7.  The human and animal baby schema effect: correlates of individual differences.

Authors:  Vicky Lehmann; Elisabeth M J Huis in't Veld; Ad J J M Vingerhoets
Journal:  Behav Processes       Date:  2013-01-23       Impact factor: 1.777

Review 8.  Sustained-release naltrexone for opioid dependence.

Authors:  P Lobmaier; H Kornør; N Kunøe; A Bjørndal
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 9.  Is social attachment an addictive disorder?

Authors:  Thomas R Insel
Journal:  Physiol Behav       Date:  2003-08

Review 10.  Pharmacologic treatments for opioid dependence: detoxification and maintenance options.

Authors:  Herbert D Kleber
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

View more
  6 in total

Review 1.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

2.  Current understanding of the neurobiology of opioid use disorder: An overview.

Authors:  Hestia Moningka; Sarah Lichenstein; Sarah W Yip
Journal:  Curr Behav Neurosci Rep       Date:  2019-01-17

3.  Parenting and addictions: Current insights from human neuroscience.

Authors:  Helena Jv Rutherford; Sohye Kim; Sarah W Yip; Marc N Potenza; Linda C Mayes; Lane Strathearn
Journal:  Curr Addict Rep       Date:  2021-07-09

Review 4.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

Review 5.  Forging Neuroimaging Targets for Recovery in Opioid Use Disorder.

Authors:  Jennifer L Stewart; April C May; Robin L Aupperle; Jerzy Bodurka
Journal:  Front Psychiatry       Date:  2019-03-07       Impact factor: 4.157

Review 6.  Bouncing back: Brain rehabilitation amid opioid and stimulant epidemics.

Authors:  Jennifer L Stewart; April C May; Martin P Paulus
Journal:  Neuroimage Clin       Date:  2019-11-05       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.